Save the New Tetracycline Omadacycline (Nuzyra) as a Last Resort

You'll see a new, once-daily, IV and PO tetracycline antibiotic, omadacycline (Nuzyra, noo-ZYE-rah).

It's approved for community-acquired pneumonia (CAP)...or skin infections, including methicillin-resistant Staph aureus (MRSA).

Evidence suggests omadacycline is non-inferior to moxifloxacin for CAP or linezolid for skin infections. And omadacycline costs about $350/IV dose or $400/oral dose.

Get unlimited access through an Enterprise license

Hospital Pharmacist's Letter includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 300+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Not sold to individuals